Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
21 07 2023
Historique:
medline: 24 7 2023
pubmed: 20 7 2023
entrez: 20 7 2023
Statut: ppublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) now arise in the context of heterogeneous human connectivity and population immunity. Through a large-scale phylodynamic analysis of 115,622 Omicron BA.1 genomes, we identified >6,000 introductions of the antigenically distinct VOC into England and analyzed their local transmission and dispersal history. We find that six of the eight largest English Omicron lineages were already transmitting when Omicron was first reported in southern Africa (22 November 2021). Multiple datasets show that importation of Omicron continued despite subsequent restrictions on travel from southern Africa as a result of export from well-connected secondary locations. Initiation and dispersal of Omicron transmission lineages in England was a two-stage process that can be explained by models of the country's human geography and hierarchical travel network. Our results enable a comparison of the processes that drive the invasion of Omicron and other VOCs across multiple spatial scales.

Identifiants

pubmed: 37471538
doi: 10.1126/science.adg6605
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

336-343

Auteurs

Joseph L-H Tsui (JL)

Department of Biology, University of Oxford, Oxford, UK.

John T McCrone (JT)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.
Helix, San Mateo, CA 94401, USA.

Ben Lambert (B)

College of Engineering, Mathematics and Physical Sciences, University of Exeter, Exeter, UK.

Sumali Bajaj (S)

Department of Biology, University of Oxford, Oxford, UK.

Rhys P D Inward (RPD)

Department of Biology, University of Oxford, Oxford, UK.

Paolo Bosetti (P)

Institut Pasteur, Université Paris Cité, CNRS, Paris, France.

Rosario Evans Pena (RE)

Department of Biology, University of Oxford, Oxford, UK.

Houriiyah Tegally (H)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

Verity Hill (V)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.
Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06511, USA.

Alexander E Zarebski (AE)

Department of Biology, University of Oxford, Oxford, UK.

Thomas P Peacock (TP)

Department of Infectious Disease, Imperial College London, London, UK.
UK Health Security Agency, London, UK.

Luyang Liu (L)

Google Research, Mountain View, CA 94043, USA.

Neo Wu (N)

Google Research, Mountain View, CA 94043, USA.

Isaac I Bogoch (II)

Department of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Canada.

Kamran Khan (K)

BlueDot, Toronto, Canada.
Department of Medicine, Division of Infectious Diseases, University of Toronto, Toronto, Canada.

Meaghan Kall (M)

UK Health Security Agency, London, UK.

Rachel Colquhoun (R)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.

Áine O'Toole (Á)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.

Ben Jackson (B)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.

Abhishek Dasgupta (A)

Department of Biology, University of Oxford, Oxford, UK.
Doctoral Training Centre, University of Oxford, Oxford, UK.

Eduan Wilkinson (E)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

Tulio de Oliveira (T)

KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Centre for Epidemic Response and Innovation (CERI), School for Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.

Thomas R Connor (TR)

Pathogen Genomics Unit, Public Health Wales NHS Trust, Cardiff, UK.
School of Biosciences, The Sir Martin Evans Building, Cardiff University, Cardiff, UK.
Quadram Institute, Norwich, UK.

Nicholas J Loman (NJ)

Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.

Vittoria Colizza (V)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Christophe Fraser (C)

Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, UK.
Pandemic Sciences Institute, University of Oxford, Oxford, UK.

Erik Volz (E)

MRC Centre of Global Infectious Disease Analysis, Jameel Institute for Disease and Emergency Analytics, Imperial College London, London, UK.

Xiang Ji (X)

Department of Mathematics, Tulane University, New Orleans, LA 70118, USA.

Bernardo Gutierrez (B)

Department of Biology, University of Oxford, Oxford, UK.
School of Biological and Environmental Sciences, Universidad San Francisco de Quito USFQ, Quito, Ecuador.

Meera Chand (M)

UK Health Security Agency, London, UK.

Simon Dellicour (S)

Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, Bruxelles, Belgium.
Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

Simon Cauchemez (S)

Institut Pasteur, Université Paris Cité, CNRS, Paris, France.

Jayna Raghwani (J)

Department of Biology, University of Oxford, Oxford, UK.
Department of Pathobiology and Population Science, Royal Veterinary College, London, UK.

Marc A Suchard (MA)

Departments of Biostatistics, Biomathematics and Human Genetics, University of California, Los Angeles, CA 90095, USA.

Philippe Lemey (P)

Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.

Andrew Rambaut (A)

Institute of Ecology and Evolution, University of Edinburgh, Edinburgh, UK.

Oliver G Pybus (OG)

Department of Biology, University of Oxford, Oxford, UK.
Pandemic Sciences Institute, University of Oxford, Oxford, UK.
Department of Pathobiology and Population Science, Royal Veterinary College, London, UK.

Moritz U G Kraemer (MUG)

Department of Biology, University of Oxford, Oxford, UK.
Pandemic Sciences Institute, University of Oxford, Oxford, UK.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH